Serum Biomarkers of a Pro-Neuroinflammatory State May Define the Pre-Operative Risk for Postoperative Delirium in Spine Surgery
Advances in spine surgery enable technically safe interventions in older patients with disabling spine disease, yet postoperative delirium (POD) poses a serious risk for postoperative recovery. This study investigates biomarkers of pro-neuroinflammatory states that may help objectively define the pre-operative risk for POD. This study enrolled patients aged ≥60 scheduled for elective spine surgery under general anesthesia. Biomarkers for a pro-neuroinflammatory state included S100 calcium-binding protein β (S100β), brain-derived neurotrophic factor (BDNF), Gasdermin D, and the soluble ectodomain of the triggering receptor expressed on myeloid cells 2 (sTREM2). Postoperative changes of Interleukin-6 (IL-6), Interleukin-1β (IL-1β), and C-reactive protein (CRP) were assessed as markers of systemic inflammation preoperatively, intraoperatively, and early postoperatively (up to 48 h). Patients with POD (n = 19, 75.7 ± 5.8 years) had higher pre-operative levels of sTREM2 (128.2 ± 69.4 pg/mL vs. 97.2 ± 52.0 pg/mL, p = 0.049) and Gasdermin D (2.9 ± 1.6 pg/mL vs. 2.1 ± 1.4 pg/mL, p = 0.29) than those without POD (n = 25, 75.6 ± 5.1 years). STREM2 was additionally a predictor for POD (OR = 1.01/(pg/mL) [1.00-1.03], p = 0.05), moderated by IL-6 (Wald-χ2 = 4.06, p = 0.04). Patients with POD additionally showed a significant increase in IL-6, IL-1β, and S100β levels on the first postoperative day. This study identified higher levels of sTREM2 and Gasdermin D as potential markers of a pro-neuroinflammatory state that predisposes to the development of POD. Future studies should confirm these results in a larger cohort and determine their potential as an objective biomarker to inform delirium prevention strategies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
International journal of molecular sciences - 24(2023), 12 vom: 19. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ruhnau, Johanna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarker |
|---|
| Anmerkungen: |
Date Completed 29.06.2023 Date Revised 01.07.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/ijms241210335 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358747945 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358747945 | ||
| 003 | DE-627 | ||
| 005 | 20231226075411.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms241210335 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1195.xml |
| 035 | |a (DE-627)NLM358747945 | ||
| 035 | |a (NLM)37373482 | ||
| 035 | |a (PII)10335 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ruhnau, Johanna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serum Biomarkers of a Pro-Neuroinflammatory State May Define the Pre-Operative Risk for Postoperative Delirium in Spine Surgery |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.06.2023 | ||
| 500 | |a Date Revised 01.07.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Advances in spine surgery enable technically safe interventions in older patients with disabling spine disease, yet postoperative delirium (POD) poses a serious risk for postoperative recovery. This study investigates biomarkers of pro-neuroinflammatory states that may help objectively define the pre-operative risk for POD. This study enrolled patients aged ≥60 scheduled for elective spine surgery under general anesthesia. Biomarkers for a pro-neuroinflammatory state included S100 calcium-binding protein β (S100β), brain-derived neurotrophic factor (BDNF), Gasdermin D, and the soluble ectodomain of the triggering receptor expressed on myeloid cells 2 (sTREM2). Postoperative changes of Interleukin-6 (IL-6), Interleukin-1β (IL-1β), and C-reactive protein (CRP) were assessed as markers of systemic inflammation preoperatively, intraoperatively, and early postoperatively (up to 48 h). Patients with POD (n = 19, 75.7 ± 5.8 years) had higher pre-operative levels of sTREM2 (128.2 ± 69.4 pg/mL vs. 97.2 ± 52.0 pg/mL, p = 0.049) and Gasdermin D (2.9 ± 1.6 pg/mL vs. 2.1 ± 1.4 pg/mL, p = 0.29) than those without POD (n = 25, 75.6 ± 5.1 years). STREM2 was additionally a predictor for POD (OR = 1.01/(pg/mL) [1.00-1.03], p = 0.05), moderated by IL-6 (Wald-χ2 = 4.06, p = 0.04). Patients with POD additionally showed a significant increase in IL-6, IL-1β, and S100β levels on the first postoperative day. This study identified higher levels of sTREM2 and Gasdermin D as potential markers of a pro-neuroinflammatory state that predisposes to the development of POD. Future studies should confirm these results in a larger cohort and determine their potential as an objective biomarker to inform delirium prevention strategies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Gasdermin D | |
| 650 | 4 | |a biomarker | |
| 650 | 4 | |a postoperative cognitive dysfunction | |
| 650 | 4 | |a postoperative delirium | |
| 650 | 4 | |a sTREM2 | |
| 650 | 4 | |a spine surgery | |
| 650 | 7 | |a Interleukin-6 |2 NLM | |
| 650 | 7 | |a Gasdermins |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Müller, Jonas |e verfasserin |4 aut | |
| 700 | 1 | |a Nowak, Stephan |e verfasserin |4 aut | |
| 700 | 1 | |a Strack, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Sperlich, Denise |e verfasserin |4 aut | |
| 700 | 1 | |a Pohl, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Dilz, Jasmin |e verfasserin |4 aut | |
| 700 | 1 | |a Saar, Angelika |e verfasserin |4 aut | |
| 700 | 1 | |a Veser, Yannick |e verfasserin |4 aut | |
| 700 | 1 | |a Behr, Frederik |e verfasserin |4 aut | |
| 700 | 1 | |a Rehberg, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Usichenko, Taras |e verfasserin |4 aut | |
| 700 | 1 | |a Hahnenkamp, Klaus |e verfasserin |4 aut | |
| 700 | 1 | |a Ehler, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Flöel, Agnes |e verfasserin |4 aut | |
| 700 | 1 | |a Schroeder, Henry W S |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Jan-Uwe |e verfasserin |4 aut | |
| 700 | 1 | |a Fleischmann, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Vogelgesang, Antje |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 24(2023), 12 vom: 19. Juni |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:12 |g day:19 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms241210335 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 12 |b 19 |c 06 | ||